ResMed Inc. (RMD)

ResMed Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	27,817	32,104	30,666	35,873	27,776	17,498
Market Cap Growth	-9.46%	4.69%	-14.52%	29.15%	58.74%	18.35%
Enterprise Value	28,746	33,456	31,309	36,371	28,612	18,622
PE Ratio	29.09	35.77	39.34	75.60	44.68	43.25
PS Ratio	6.07	7.60	8.57	11.22	9.39	6.71
PB Ratio	6.01	7.77	9.13	12.43	11.12	8.44
P/FCF Ratio	25.53	55.97	141.77	56.58	39.29	44.83
P/OCF Ratio	23.21	46.31	87.33	48.69	34.62	38.12
EV/Sales Ratio	6.27	7.92	8.75	11.38	9.68	7.14
EV/EBITDA Ratio	19.75	24.84	26.61	33.10	30.00	26.38
EV/EBIT Ratio	23.21	29.12	31.86	40.09	37.04	33.55
EV/FCF Ratio	26.38	58.32	144.74	57.37	40.47	47.71
Debt / Equity Ratio	0.25	0.38	0.27	0.28	0.52	0.61
Debt / EBITDA Ratio	0.80	1.17	0.78	0.72	1.36	1.80
Debt / FCF Ratio	1.07	2.75	4.24	1.25	1.84	3.26
Quick Ratio	1.32	1.23	1.23	1.00	1.56	1.22
Current Ratio	3.04	3.12	2.80	1.73	2.53	2.06
Asset Turnover	0.67	0.67	0.74	0.69	0.67	0.69
Interest Coverage	22.63	24.25	44.05	38.40	19.63	15.35
Return on Equity (ROE)	21.90%	23.60%	24.30%	17.00%	27.20%	20.40%
Return on Assets (ROA)	14.10%	14.20%	16.00%	10.30%	14.10%	10.70%
Return on Capital (ROIC)	16.95%	16.15%	18.97%	13.19%	18.09%	13.51%
Earnings Yield	3.45%	2.80%	2.54%	1.32%	2.24%	2.31%
FCF Yield	3.92%	1.79%	0.71%	1.77%	2.55%	2.23%
Dividend Yield	1.01%	0.80%	0.80%	0.60%	0.80%	1.20%
Payout Ratio	29.49%	28.80%	31.50%	47.70%	36.20%	52.30%
Buyback Yield / Dilution	-0.04%	-0.28%	-0.40%	-0.55%	-0.81%	-0.35%
Total Shareholder Return	0.98%	0.52%	0.40%	0.05%	-0.01%	0.85%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).